FYF-18980-17702
3 vaccinations
1 coded response
10 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 967 / HI
- Registered
- 2021-01-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Dose 1 — Pfizer-BioNTech
-
2021-01-26
Dose 2 — Pfizer-BioNTech
-
2021-01-31
Registered in v-safe
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue, Headache, Myalgia, Pain in extremity, Pyrexia — Feeling: Good · Site: PainFree text: Headache LOW grade fever muscle aches fatigue day after shot that resolved after 24 hours. Arm sore as well but no local reaction and also resolved.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-01
- 2021-02-23
- 2021-03-02
- 2021-03-11
- 2021-07-28
-
2021-08-27
Dose 3 — Pfizer-BioNTech
- 2021-10-02
- 2021-10-08
- 2022-02-25
- 2022-08-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Pfizer-BioNTech | |
| 2 | 2021-01-26 | Pfizer-BioNTech | |
| 3 | 2021-08-27 | Pfizer-BioNTech | No |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Headache LOW grade fever muscle aches fatigue day after shot that resolved after 24 hours. Arm sore as well but no local reaction and also resolved.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
| SRO | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release